UBS AM’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.5M | Buy |
1,319,792
+254,868
| +24% | +$14M | 0.01% | 604 |
|
|
2025
Q1 | $75.3M | Buy |
1,064,924
+9,837
| +0.9% | +$695K | 0.02% | 600 |
|
|
2024
Q4 | $69.4M | Buy |
1,055,087
+174,634
| +20% | +$11.5M | 0.02% | 595 |
|
|
2024
Q3 | $61.9M | Sell |
880,453
-132,587
| -13% | -$9.32M | 0.02% | 629 |
|
|
2024
Q2 | $83.4M | Buy |
1,013,040
+268,239
| +36% | +$22.1M | 0.02% | 498 |
|
|
2024
Q1 | $65.1M | Sell |
744,801
-1,839
| -0.2% | -$161K | 0.02% | 544 |
|
|
2023
Q4 | $72M | Sell |
746,640
-9,696
| -1% | -$935K | 0.03% | 507 |
|
|
2023
Q3 | $66.9M | Sell |
756,336
-100,693
| -12% | -$8.91M | 0.03% | 501 |
|
|
2023
Q2 | $83.3M | Hold |
857,029
| – | – | 0.04% | 434 |
|
|
2023
Q1 | $83.3M | Sell |
857,029
-156,532
| -15% | -$15.2M | 0.04% | 434 |
|
|
2022
Q4 | $105M | Sell |
1,013,561
-260,605
| -20% | -$27M | 0.06% | 369 |
|
|
2022
Q3 | $108M | Sell |
1,274,166
-288,199
| -18% | -$24.4M | 0.06% | 351 |
|
|
2022
Q2 | $129M | Buy |
1,562,365
+10,748
| +0.7% | +$891K | 0.07% | 311 |
|
|
2022
Q1 | $120M | Buy |
1,551,617
+419,371
| +37% | +$32.3M | 0.05% | 378 |
|
|
2021
Q4 | $100M | Buy |
1,132,246
+45,170
| +4% | +$3.99M | 0.04% | 462 |
|
|
2021
Q3 | $84M | Sell |
1,087,076
-954,407
| -47% | -$73.8M | 0.03% | 487 |
|
|
2021
Q2 | $170M | Sell |
2,041,483
-196,578
| -9% | -$16.4M | 0.07% | 292 |
|
|
2021
Q1 | $169M | Sell |
2,238,061
-224,204
| -9% | -$16.9M | 0.07% | 281 |
|
|
2020
Q4 | $216M | Buy |
2,462,265
+444,701
| +22% | +$39M | 0.1% | 207 |
|
|
2020
Q3 | $153M | Buy |
2,017,564
+848,740
| +73% | +$64.6M | 0.08% | 236 |
|
|
2020
Q2 | $144M | Sell |
1,168,824
-137,364
| -11% | -$16.9M | 0.09% | 227 |
|
|
2020
Q1 | $110M | Sell |
1,306,188
-40,972
| -3% | -$3.46M | 0.08% | 247 |
|
|
2019
Q4 | $114M | Buy |
1,347,160
+194,514
| +17% | +$16.4M | 0.07% | 298 |
|
|
2019
Q3 | $77.7M | Buy |
1,152,646
+137,044
| +13% | +$9.24M | 0.05% | 374 |
|
|
2019
Q2 | $87M | Sell |
1,015,602
-152,762
| -13% | -$13.1M | 0.06% | 339 |
|
|
2019
Q1 | $104M | Sell |
1,168,364
-15,858
| -1% | -$1.41M | 0.08% | 280 |
|
|
2018
Q4 | $101M | Buy |
1,184,222
+64,718
| +6% | +$5.51M | 0.09% | 254 |
|
|
2018
Q3 | $109M | Sell |
1,119,504
-58,085
| -5% | -$5.63M | 0.08% | 272 |
|
|
2018
Q2 | $111M | Buy |
1,177,589
+28,971
| +3% | +$2.73M | 0.09% | 269 |
|
|
2018
Q1 | $93.1M | Buy |
1,148,618
+10,276
| +0.9% | +$833K | 0.07% | 301 |
|
|
2017
Q4 | $102M | Buy |
1,138,342
+79,591
| +8% | +$7.1M | 0.09% | 266 |
|
|
2017
Q3 | $98.5M | Sell |
1,058,751
-12,488
| -1% | -$1.16M | 0.09% | 251 |
|
|
2017
Q2 | $97.3M | Sell |
1,071,239
-16,756
| -2% | -$1.52M | 0.09% | 251 |
|
|
2017
Q1 | $95.5M | Buy |
1,087,995
+110,504
| +11% | +$9.7M | 0.1% | 230 |
|
|
2016
Q4 | $81M | Sell |
977,491
-103,601
| -10% | -$8.58M | 0.09% | 244 |
|
|
2016
Q3 | $100M | Sell |
1,081,092
-18,369
| -2% | -$1.7M | 0.11% | 218 |
|
|
2016
Q2 | $85.5M | Sell |
1,099,461
-48,178
| -4% | -$3.75M | 0.1% | 233 |
|
|
2016
Q1 | $94.7M | Buy |
1,147,639
+96,052
| +9% | +$7.92M | 0.11% | 206 |
|
|
2015
Q4 | $110M | Sell |
1,051,587
-32,399
| -3% | -$3.39M | 0.13% | 183 |
|
|
2015
Q3 | $114M | Sell |
1,083,986
-34,773
| -3% | -$3.66M | 0.13% | 183 |
|
|
2015
Q2 | $153M | Sell |
1,118,759
-166,660
| -13% | -$22.8M | 0.15% | 154 |
|
|
2015
Q1 | $160M | Buy |
1,285,419
+139,945
| +12% | +$17.4M | 0.15% | 153 |
|
|
2014
Q4 | $104M | Sell |
1,145,474
-553
| -0% | -$50K | 0.1% | 233 |
|
|
2014
Q3 | $82.7M | Buy |
1,146,027
+24,253
| +2% | +$1.75M | 0.08% | 267 |
|
|
2014
Q2 | $69.8M | Buy |
1,121,774
+9,881
| +0.9% | +$615K | 0.07% | 302 |
|
|
2014
Q1 | $75.8M | Buy |
1,111,893
+270,465
| +32% | +$18.4M | 0.08% | 276 |
|
|
2013
Q4 | $59.1M | Sell |
841,428
-67,517
| -7% | -$4.74M | 0.07% | 319 |
|
|
2013
Q3 | $65.6M | Buy |
908,945
+58,274
| +7% | +$4.21M | 0.08% | 274 |
|
|
2013
Q2 | $47.5M | Buy |
+850,671
| New | +$47.5M | 0.06% | 326 |
|